Publicaciones en colaboración con investigadores/as de Örebro University (37)

2024

  1. Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD study

    Alzheimer's and Dementia, Vol. 20, Núm. 10, pp. 6722-6739

  2. Blood-based multivariate methylation risk score for cognitive impairment and dementia

    Alzheimer's and Dementia, Vol. 20, Núm. 10, pp. 6682-6698

  3. One-year employment outcome prediction after traumatic brain injury: A CENTER-TBI study

    Disability and Health Journal

2023

  1. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  2. Prognostic Models for Global Functional Outcome and Post-Concussion Symptoms Following Mild Traumatic Brain Injury: A Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) Study

    Journal of Neurotrauma, Vol. 40, Núm. 15-16, pp. 1651-1670

  3. Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients

    British Journal of Surgery, Vol. 110, Núm. 12, pp. 1863-1876

  4. Surgical management of acute appendicitis during the European COVID-19 second wave: safe and effective

    European Journal of Trauma and Emergency Surgery, Vol. 49, Núm. 1, pp. 57-67

  5. Techniques for mesoappendix transection and appendix resection: insights from the ESTES SnapAppy study

    European Journal of Trauma and Emergency Surgery, Vol. 49, Núm. 1, pp. 17-32

  6. Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits

    Alzheimer's and Dementia, Vol. 19, Núm. 6, pp. 2317-2331

2022

  1. An Integrated Care Platform System (C3-Cloud) for Care Planning, Decision Support, and Empowerment of Patients With Multimorbidity: Protocol for a Technology Trial

    JMIR Research Protocols, Vol. 11, Núm. 7

  2. Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease

    Molecular neurodegeneration, Vol. 17, Núm. 1, pp. 27

  3. Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease (Molecular Neurodegeneration, (2022), 17, 1, (27), 10.1186/s13024-022-00521-3)

    Molecular Neurodegeneration

  4. Health care utilization and outcomes in older adults after Traumatic Brain Injury: A CENTER-TBI study

    Injury, Vol. 53, Núm. 8, pp. 2774-2782

  5. Measurement invariance of six language versions of the post-traumatic stress disorder checklist for DSM-5 in civilians after traumatic brain injury

    Scientific Reports, Vol. 12, Núm. 1

  6. Neurocognitive correlates of probable posttraumatic stress disorder following traumatic brain injury

    Brain and Spine, Vol. 2

  7. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum

    JAMA Neurology, Vol. 79, Núm. 3, pp. 228-243

  8. Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation

    Molecular Psychiatry, Vol. 27, Núm. 4, pp. 1990-1999

  9. Serum metabolome associated with severity of acute traumatic brain injury

    Nature Communications, Vol. 13, Núm. 1

2021

  1. Csf proteomic alzheimer’s disease-predictive subtypes in cognitively intact amyloid negative individuals

    Proteomes, Vol. 9, Núm. 3

  2. Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders

    Nature Genetics, Vol. 53, Núm. 11, pp. 1543-1552